Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
KNSA
Stock Latest News
Company Announcements
Kiniksa Pharmaceuticals Reports Strong Q2 2025 Growth
3d ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Reports Strong ARCALYST Growth
3d ago
KNSA
Premium
The Fly
Kiniksa price target raised to $54 from $45 at Jefferies
3d ago
KNSA
Premium
The Fly
Kiniksa reports Q2 EPS 23c, consensus 26c
4d ago
KNSA
Premium
The Fly
Kiniksa raises FY25 ARCALYST revenue view to $625M-$640M from $590M-$605M
4d ago
KNSA
Premium
Pre-Earnings
KNSA Earnings this Week: How Will it Perform?
6d ago
KNSA
Premium
The Fly
Kiniksa price target raised to $42 from $30 at Wells Fargo
24d ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Unveils Phase 2/3 Trial Plans
2M ago
8K
KNSA
Premium
The Fly
Kiniksa announces details for planned 2/3 trial of KPL-387
2M ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Annual Shareholders Meeting Decisions
2M ago
8K
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Q1 2025 Earnings: Strong Growth
3M ago
KNSA
Premium
The Fly
Kiniksa announces Carly Pearce joined the Life DisRPted Campaign
3M ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Reports Strong Q1 2025 Growth
3M ago
KNSA
Premium
The Fly
Kiniksa price target raised to $45 from $40 at Jefferies
3M ago
KNSA
Premium
The Fly
Kiniksa reports Q1 EPS 11c, consensus 28c
3M ago
KNSA
Premium
The Fly
Kiniksa sees FY25 ARCALYST net product revenue $590M-$605M
3M ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Approves Long-Term Incentive Plan
3M ago
8K
KNSA
Premium
The Fly
Kiniksa initiated with a Buy at Citi
5M ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Reports Strong Growth Amid Challenges
5M ago
KNSA
Premium
The Fly
Kiniksa price target lowered to $30 from $35 at Wells Fargo
5M ago
KNSA
Premium
Ratings
Buy Rating for Kiniksa Pharmaceuticals Driven by Strategic Refocus and Commercial Success
5M ago
KNSA
Premium
Ratings
Kiniksa Pharmaceuticals: Strategic Focus on Cardiovascular Growth and Stability Underpins Buy Rating
5M ago
KNSA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
